Cell-lineage regulated myogenesis for dystrophin replacement: A novel therapeutic approach for treatment of muscular dystrophy

Human Molecular Genetics

Volumn 17, Issue 16, 2008, Pages 2507-2517

  Kimura, En ^a   Han, Jay J ^a   Li, Sheng ^a   Fall, Brent ^a   Ra, Jennifer ^a   Haraguchi, Miki ^a   Tapscott, Stephen J ^a,b   Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MYOD PROTEIN; TAMOXIFEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FIBROBLAST; GENE EXPRESSION; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; VIRAL GENE THERAPY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; DYSTROPHIN; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; MYOD PROTEIN; NIH 3T3 CELLS; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS;

MUS;

EID: 48249119884     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn151     Document Type: Article

References (56)

1. Koenig, M., Monaco, A.P. and Kunkel, L.M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell, 53, 219-226.
2. Hoffman, E.P., Brown, R.H., Jr and Kunkel, L.M. (1987) Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
3. Bushby, K.M., Thambyayah, M. and Gardner-Medwin, D. (1991) Prevalence and incidence of Becker muscular dystrophy. Lancet, 337, 1022-1024.
4. Bushby, K.M., Hill, A. and Steele, J.G. (1999) Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet, 353, 557-558.
5. Eagle, M., Baudouin, S.V., Chandler, C., Giddings, D.R,, Bullock, R. and Bushby, K. (2002) Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord., 12, 926-929.
6. Chamberlain, J.S. and Rando, T.A. (eds) (2006) Duchenne Muscular Dystrophy: Advances in Therapeutics, Taylor and Francis, New York.
7. Uchino, M., Araki, S., Miike, T., Teramoto, H., Nakamura, T. and Yasutake, T. (1989) Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders. Muscle Nerve, 12, 1009-1016.
8. Campbell, K.P. (1995) Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage. Cell, 80, 675-679.
9. Cox, G.A., Phelps, S.F., Chapman, V.M. and Chamberlain, J.S. (1993) New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat. Genet., 4, 87-93.
10. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA, 90, 3710-3714.
11. Turner, P.R., Westwood, T., Regen, C.M. and Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 335, 735-738.
12. Emery, A.E. and Muntoni, F. (2003) Duchenne Muscular Dystrophy., 3rd edn. Oxford University Press, Oxford.
13. Engel, A.G., Yamamoto, M. and Fischbeck, K.H. (1994) Dystrophinopathies. In Engel, A.G. and Franzini-Armstrong, C. (eds), Myology, 2 edn. McGraw-Hill, New York, Vol. 2, pp. 1130-1187.
14. DelloRusso, C., Scott, J.M., Hartigan-O'Connor, D., Salvatori, G., Barjot, C., Robinson, A.S., Crawfbrd, R.W., Brooks, S.V. and Chamberlain, J.S. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc. Natl. Acad. Sci. USA, 99, 12979-12984.
15. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W., Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V. et al. (2002) Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8 253-261.
16. Gregorevic, P., Blankinship, M.J., Allen, J.M., Crawford, R.W., Meuse, L., Miller, D.G., Russell, D.W. and Chamberlain, J.S. (2004) Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med., 10, 828-834.
17. Blankinship, M.J., Gregorevic, P., Allen, J.M., Harper, S.Q., Harper, H., Halbert, C.L., Miller, D.A. and Chamberlain, J.S. (2004) Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther., 10, 671-678.
18. Li, S., Kimura, E., Fall, B.M., Reyes, M., Angello, J.C., Welikson, R., Hauschka, S.D. and Chamberlain, J.S. (2005) Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther., 12, 1099-1108.
19. Gregorevic, P., Allen, J.M., Minami, E., Blankinship, M.J., Haraguchi, M., Meuse, L., Finn, E., Adams, M.E., Froehner, S.C., Murry, C.E. et al. (2006) rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat. Med., 12, 787-789.
20. Gregorevic, P., Blankinship, M.J., Allen, J.M. and Chamberlain, J.S. (2008) Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol. Ther. 16, 657-664.
21. Webster, C. and Blau, H.M. (1990) Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy. Somat. Cell Mol. Genet., 16, 557-565.
22. Gussoni, E., Pavlath, G.K., Lanctot, A.M., Sharma, K.R., Miller, R.G., Steinman, L. and Blau, H.M. (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature, 356, 435-438.
23. Karpati, G., Ajdukovic, D., Arnold, D., Gledhill, R.B., Guttmann, R., Holland, P., Koch, P.A., Shoubridge, E., Spence, D., Vanasse, M. et al. (1993) Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol., 34, 8-17.
24. Tremblay, J.P., Malouin, F., Roy, R., Huard, J., Bouchard, J.P., Satoh, A. and Richards, C.L. (1993) Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant., 2, 99-112.
25. Mendell, J.R., Kissel, J.T., Amato, A.A., King, W., Signore, L., Prior, T.W., Sahenk, Z., Benson, S., McAndrew, P.E., Rice, R. et al. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med., 333, 832-838.
26. Partridge, T. (2002) Myoblast transplantation. Neuromuscul. Disord. 12 (Suppl 1), S3-S6.
27. Lapidos, K.A., Chen, Y.E., Earley, J.U., Heydemann, A., Huber, J.M., Chien, M., Ma, A. and McNally, E.M. (2004) Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J. Clin. Invest., 114, 1577-1585.
28. Gussoni, E., Blau, H.M. and Kunkel, L.M. (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med., 3, 970-977.
29. Salvatori, G., Ferrari, G., Mezzogiorno, A., Servidei, S., Coletta, M., Tonali, P., Giavazzi, R., Cossu, G. and Mavilio, F. (1993) Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers. in vivo. Hum. Gene Ther., 4, 713-723.
30. Mouly, V., Aamiri, A., Perie, S., Mamchaoui, K., Barani, A., Bigot, A., Bouazza, B., Francois, V., Furling, D., Jacquemin, V. et al. (2005) Myoblast transfer therapy: Is there any light at the end of the tunnel? Acta Myol., 24, 128-133.
31. Kunkel, L.M., Bachrach, E., Bennett, R.R., Guyon, J. and Steffen, L. (2006) Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish. J. Hum. Genet., 51, 397-406.
32. Lattanzi, L., Salvatori, G., Coletta, M., Sonnino, C., Cusella De Angelis M.G., Gioglio, L., Murry, C.E., Kelly, R., Ferrari, G., Molinaro, M. et al. (1998) High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathics. J. Clin. Invest., 101, 2119-2128.
33. Huard, C., Moisset, P.A., Dicaire, A., Merly, F., Tardif, F., Asselin, I. and Tremblay, J.P. (1998) Transplantation of dermal fibroblasts expressing MyoD1 in mouse muscles. Biochem. Biophys. Res. Commun., 248, 648-654.
34. Davis, R.L., Weintraub, H. and Lassar, A.B. (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell, 51, 987-1000.
35. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T.K., Turner, D., Rupp, R., Hollenberg, S. et al. (1991) The MyoD gene family: Nodal point during specification of the muscle cell lineage. Science, 251, 761-766.
36. Gibson, A.J., Karasinski, J., Relvas, J., Moss, J., Sherratt, T.G., Strong, P.N. and Watt, D.J. (1995) Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. J. Cell Sci., 108 207-214.
37. Salvatori, G., Lattanzi, L., Coletta, M., Agostino, S., Vivarelli, E., Kelly, R., Ferrari, G., Harris, A.J., Mavilio, F., Molinaro, M. et al. (1995) Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells. J. Cell Sci., 108, 2733-2739.
38. West, T.B. and Alster, T.S. (1998) Autologous human collagen and dermal fibroblasts for soft time augmentation. Dermatol. Surg., 24, 510-512.
39. Lim, R.W. and Hauschka, S.D. (1984) EGF responsiveness and receptor regulation in normal and differentiation-defective mouse myoblasts. Dev. Biol., 105, 48-58.
40. Emslie-Smith, A.M., Arahata, K. and Engel, A.G. (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated. cytotoxicity in myopathies. Hum. Pathol., 20, 224-231.
41. McMichael, A.J. (1980) HLA restriction of human cytotoxic T cells. Springer Semin. Immunopathol., 3, 3-22.
42. Hartigan-O'Connor, D., Kirk, C.J., Crawford, R., Mule, J.J. and Chamberlain, J.S. (2001) Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol. Ther., 4, 525-533.
43. Danielian, P.S., White, R., Hoare, S.A., Fawell, S.E. and Parker, M.G. (1993) Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol., 7, 232-240.
44. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
45. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
46. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
47. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
48. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S., Ide, C. and Nabeshima, Y. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309, 314-317.
49. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., Tagliafico, E., Sacchetti, B., Perani, L., Innocenzi, A., Galvez, B.G., Messina, G., Morosetti, R. et al. (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267.
50. Sampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M.A., Barresi, R., Bresolin, N., De Angelis, M.G., Campbell, K.P. et al. (2003) Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science, 301, 487-492.
51. Torrente, Y., Belicchi, M., Sampaolesi, M., Pisati, F., Meregalli, M., D'Antona, G,, Tonlorenzi, R., Porretti, L., Gavina, M., Mamchaoui, K. et al. (2004) Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest., 114, 182-195.
52. Hollenberg, S.M., Cheng, P.F. and Weintraub, H. (1993) Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. USA 90, 8028-8032.
53. Barry, S.C., Harder, B., Brzezinski, M., Flint, L.Y., Seppen, J. and Osborne, W.R. (2001) Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Hum. Gene Ther., 12, 1103-1108.
54. Balcaitis, S., Weinstein, J.R., Li, S., Chamberlain, J.S. and Moller, T. (2005) Lentiviral transduction of microglial cells. Glia, 50 48-55.
55. Kuhbandner, S., Brummer, S., Metzger, D., Chambon, P., Hofmann, F. and Feil, R. (2000) Temporally controlled somatic mutagenesis in smooth muscle. Genesis, 28, 15-22.
56. Li, S., Kimura, E., Ng, R., Fall, B.M., Meuse, L., Reyes, M., Faulkner, J.A. and Chamberlain, J.S. (2006) A highly functional mini-dystrophin/ GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy. Hum. Mol. Genet., 15, 1610-1622.